Global Asset Management Seoul Korea

UDR, Inc. (the "Company”) (NYSE: UDR) announced today that it has priced the previously announced cash tender offer for any and all of its outstanding 3.750% medium-term notes due 2024 (CUSIP No. 90265E AJ9) (the "Notes”), on the terms and subject to the conditions set forth in the Offer to Purchase, dated July 14, 2020 (the "Offer to Purchase”), and the related Notice of Guaranteed Delivery attached to the Offer to Purchase (the "Notice of Guaranteed Delivery”). The Notes are fully and unconditionally guaranteed by United Dominion Realty, L.P. The tender offer is referred to herein as the "Offer.” The Offer to Purchase and the Notice of Guaranteed Delivery are referred to herein collectively as the "Offer Documents.” Certain information regarding the Notes and the pricing for the Offer is set forth in the table below. Title of Security CUSIP Number Principal Amount Outstanding U.S. Treasury Reference Security Bloomberg Reference Page Reference Yield Fixed

(RTTNews) - Shares of Immuron Ltd. (IMRN) are rallying over 76% in pre-market today, after the company announced that the Naval Medical Research Center or NMRC has received written guidance from the U.S. FDA in relation to the clinical development pathway of a new investigational drug which the company is developing to treat moderate to severe campylobacteriosis and Enterotoxigenic Escherichia coli or ETEC infections. Highlights: * Two human phase II clinical trials to be conducted in 2021. * One trial will focus on the ability of the hyperimmune product to protect volunteers against moderate to severe campylobacteriosis. * The second trial will focus on ETEC infections. The stock has been trading in the range of $1.55 - $28.99 for the past one year, and closed Friday's trade at $6.37, up 22 cents or 3.58%. IMRN is currently trading at $11.25, up $4.88 or 76.61% in the pre-market session. To keep reading about Stock Alert: Immuron Shares Soar 76% In Early Trade, Click on the link

(RTTNews) - Grifols (GRFS) said that it has executed purchase agreements with the South Korean-based GC Pharma (Group) whereby Grifols will acquire the Montreal-based plasma fractionation facility and two purification facilities, along with 11 U.S.-based plasma collection centers for US$460 million. Once the facilities are fully licensed and approved, Grifols will become the only large-scale commercial manufacturer of plasma products in Canada, with a fractionation capacity of 1.5 million liters annually, the company said in a statement. Grifols plans to be ready to manufacture IVIG and Albumin in the facilities to supply the Canadian market starting in 2023. As part of the transaction, Grifols has also committed to supplying certain output of plasma arising out of the Green Cross Collection Centers to GC Pharma (Group) for a 24-month period. The completion of the transaction is expected to close prior to the end of 2020. To keep reading about Grifols To Buy Plasma Fractionation Faci

ICYMI: All your Asset management needs with Global Asset Management Seoul Korea MagazineThis post was originally published on this site To keep reading about China blasts dam to release floodwaters as death toll rises, Click on the link. Seoul, Korea http://dlvr.it/Rbz4Gk

ICYMI: TEMPE, Ariz., July 18, 2020 /PRNewswire-PRWeb/ -- SparkLabs Group (https://www.sparklabsgroup.com), a global network of startup accelerators and venture capital funds, will be hosting a virtual Demo Day for their newest accelerator, SparkLabs Frontier-ASU. SparkLabs Frontier-ASU Demo Day 1 will virtually bring together entrepreneurs, investors, corporate executives, media, and government leaders interested in engaging with its most recent accelerator startup graduates. In addition to showcasing their startups, Dr. Jonny Kim, NASA astronaut, Navy SEAL, and Harvard medical graduate is slated as the keynote speaker for the event. Ji Mi Choi, AVP of ASU Entrepreneurship + Innovation, will also be speaking at the event about the partnership between SparkLabs Group and ASU Entrepreneurship + Innovation. "Demo Day is the culmination of our program where our founders have the opportunity to highlight their vision and the impact of their business to attract investment and funding.

ICYMI: Lynwood, Calif., July 18, 2020 (GLOBE NEWSWIRE) -- Verity Health and St. Francis Medical Center announced today that the California Attorney General has conditionally approved Verity Health’s application to transfer ownership of St. Francis Medical Center to Prime Healthcare. “Achieving this milestone is an important step in ensuring Prime is able to preserve the St. Francis mission for the benefit of associates, members of the medical staff and most importantly the patients and Southeast Los Angeles community that have relied on St. Francis for 75 years,” said Rich Adcock, CEO of Verity Health. In early April, the U.S. Bankruptcy Court for the Central District of California in Los Angeles approved the Asset Purchase Agreement (APA) for the sale of St. Francis Medical Center to Prime. Under the agreement, Prime will acquire St. Francis for a net consideration of over $350 million, including a $200 million base cash price and $60 million for accounts receivable. In addition, Pr

ICYMI: All your Asset management needs with Global Asset Management Seoul Korea MagazineThis post was originally published on this site To keep reading about Floods kill 14 in China as water peaks at Three Gorges Dam, Click on the link. Seoul, Korea http://dlvr.it/RbwzRy